Safety, Tolerability and efficacy of Rapid Optimization, helped by NT‐proBNP and GDF‐15, of Heart Failure therapies (STRONG‐HF): rationale and design for a multicentre, randomized, parallel‐group study
暂无分享,去创建一个
P. Ponikowski | K. Sliwa | R. Diaz | G. Filippatos | A. Mebazaa | A. Damasceno | M. Metra | J. Čelutkienė | A. Voors | A. Kimmoun | Koji Takagi | G. Cotter | O. Chioncel | A. C. Solal | B. Davison | F. Addad | M. Sani | H. Duengen | E. Goncalvesova | Z. Shogenov | I. Merai | D. Privalov